BCL2L1 and breast cancer: Thus, the present study proposes that variation in the SNP rs3208684 A>C may mediate the upregulation of Bcl-xL protein expression by interfering with the binding of let-7b to the 3′-UTR of Bcl-xL in breast cancer cells.